As of Apr 21
| +0.15 / +1.12%|
The 11 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 12.00, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a -11.11% decrease from the last price of 13.50.
The current consensus among 12 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.